Sinolink: Three major gears of commercial space are accelerating. It is recommended to focus on areas such as rocket recovery and 3D printing.
Recently, the National Space Administration has established a commercial space company, and related businesses are gradually being conducted. This marks the establishment of a dedicated regulatory agency for China's commercial space industry, which will continue to promote the high-quality development of China's commercial space industry in the future, and the entire industry chain is expected to benefit.
Sinolink released a research report stating that recently, the National Space Administration has established a commercial space department, and related businesses are gradually being carried out. This marks the official establishment of a regulatory agency for China's commercial space industry, which will continue to promote the high-quality development of China's commercial space industry in the future, with the industry chain expected to benefit across the board. China's breakthrough in reusable rocket technology is imminent, and the industry is gradually becoming self-sufficient. Currently, the aerospace industry is in a rapid development stage from 1 to 10, and the bottleneck of reusable rocket technology is expected to be quickly overcome. The aerospace field has high requirements for the strength, lightweight, and integration of complex structures of components, which naturally couples with the characteristics of 3D printing. The widespread application of 3D printing is expected to reshape the aerospace era.
Sinolink's main points are as follows:
Event: On December 26th, the Shanghai Stock Exchange issued the "Guidelines for the Application of the Shanghai Stock Exchange Issuance and Listing Review Rules Applicable to Commercial Rocket Companies under the Fifth Set of Listing Standards of the Science and Technology Innovation Board," aiming to expand the application of the fifth set of listing standards of the Science and Technology Innovation Board in the field of commercial aerospace to accelerate the innovation and development of commercial aerospace and actively serve the strategy of building a strong aerospace nation. This may accelerate the IPO process for commercial rocket companies, and the three major gears of the aerospace era are accelerating.
Frequent support policies to escort the development of the aerospace industry
In 2014, policies encouraging private capital to participate in the construction of national civil space infrastructure were introduced, marking the beginning of the aerospace era. Commercial aerospace has been included in the government work reports for 2024-2025, indicating an increase in attention. The development of the aerospace industry is also emphasized in the "Fifteen-Five" plan. In November 2025, Xinhua News Agency reported that the National Space Administration issued the "Action Plan of the National Space Administration to Promote the High-Quality Safe Development of Commercial Aerospace (2025-2027)," which outlined 22 key measures in five areas to promote the high-quality development and high-level safety of commercial aerospace. It specifies, "encouraging commercial aerospace entities to lay out corresponding links in the aerospace industry chain," "supporting commercial aerospace entities to develop new technologies and products and explore new applications," and "improving the investment and financing system for commercial aerospace, and establishing a national commercial aerospace fund," among others.
According to a report by Xinhua News Agency in November 2025, the National Space Administration has recently established a commercial space department, and related businesses are gradually being carried out, marking the official establishment of a regulatory agency for China's commercial space industry, which will continue to promote the high-quality development of China's commercial space industry in the future, with the industry chain expected to benefit across the board. According to reports by Caijing,...
Related Articles

HAOHAI BIOTEC (06826) spent 1.5342 million Hong Kong dollars to repurchase 61,000 shares on December 29th.

HUADIAN POWER (01071) completes the issuance of 3 billion yuan corporate bonds.

Wanbang Pharmaceutical Holding Group (002082.SZ) subsidiary drug WP107 obtains ethical approval.
HAOHAI BIOTEC (06826) spent 1.5342 million Hong Kong dollars to repurchase 61,000 shares on December 29th.

HUADIAN POWER (01071) completes the issuance of 3 billion yuan corporate bonds.

Wanbang Pharmaceutical Holding Group (002082.SZ) subsidiary drug WP107 obtains ethical approval.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


